Evidence mapPaperPMID 40565712Full record

ReviewFoods (Basel, Switzerland)2025

Production Methods, Biological Activity and Potential Application Prospects of Astaxanthin.

Fajian Ren, Chaolong Rao, Qiwen Xiang, Jiayu Wen, Qiuju Dai, He Li, Jiayu Liang, Yan Chen, Cheng Peng

Abstract readReview
In one paragraph

Review in Foods (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Astaxanthin fromMarine drugs · 2025
    Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Fajian RenSchool of Public Health, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Chaolong RaoSchool of Public Health, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Qiwen XiangSchool of Public Health, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Jiayu WenSchool of Public Health, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Qiuju DaiSchool of Public Health, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
He LiSchool of Public Health, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Jiayu LiangSchool of Public Health, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Yan ChenSchool of Public Health, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Cheng PengState Key Laboratory of Traditional Chinese Medicine Resources in Southwest China, Chengdu 611137, China.

Funding

Key Project of Sichuan Natural Science Foundation No. 2024NSFSC0054Regional Key Project of National Natural Science Foundation No. U24A20790Science and Technology Research Project of Sichuan Administration of Traditional Chinese Medicine 2024ZD02
6 · The paper itself

Abstract

Astaxanthin (AST), a ketocarotenoid, is prevalent in aquatic life forms. AST has a variety of health-promoting effects, such as anti-oxidation, anti-cancer, eye protection, anti-inflammatory, immune regulation, skin care, anti-diabetes, neuroprotection, etc. It holds significant potential for applications in healthcare products, food additives, pharmaceuticals, cosmetics, and aquaculture. The production capacity of AST limits its wide application to a certain extent. The instability and safety risks associated with the chemical synthesis of AST have led to increased interest in its biosynthetic pathway. In this paper, the synthesis pathway, biological activity, and application prospects of AST were reviewed. To enhance the market accessibility of AST, investigating innovative synthesis techniques and its emergent biological effects is crucial.

Indexed as

application prospectsastaxanthinbiological activityketocarotenoidmechanismssource

Identifiers

PMID40565712
PMCPMC12192321

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.